Results 141 to 150 of about 27,824 (249)

Classification of Asymptomatic Autoimmune Thyroiditis by Thyrotropin-Releasing Hormone Loading

open access: bronze, 1986
Kazumi Notsu   +7 more
openalex   +2 more sources

Quality Measures to Enhance the Management and Treatment of Primary Biliary Cholangitis: A Delphi Consensus Study

open access: yesLiver International, Volume 45, Issue 6, June 2025.
ABSTRACT Background & Aims Primary Biliary Cholangitis (PBC) is a chronic autoimmune liver disease characterised by bile duct destruction, leading to cholestasis and fibrosis. Despite therapeutic advancements, gaps remain in diagnostic standardisation, treatment response evaluation, and patient‐centred care. This study aimed to develop consensus‐driven
Domenico Alvaro   +11 more
wiley   +1 more source

AUTOIMMUNE THYROIDITIS

open access: yes
Autoimmune thyroiditis is an autoimmune disease that affects the thyroid gland. Autoimmune thyroiditis is ten times more common in women than in men. Symptoms usually first appear between the ages of 30 and 50. The overall incidence increases with age in both men and women.
openaire   +2 more sources

All‐Cause Mortality and Suicide Mortality in Patients With Tic Disorder: An Entire Population Longitudinal Study in Taiwan

open access: yesSuicide and Life-Threatening Behavior, Volume 55, Issue 3, June 2025.
ABSTRACT Background Few studies investigate cause‐specific mortality in individuals with tic disorders. We aimed to examine all‐cause, natural‐cause, and unnatural‐cause mortality in individuals with tic disorders. Methods Using the nationwide database of Taiwan from 2003 to 2017, we identified 50,018 patients with tic disorders and, using a ratio of 1:
Tien‐Wei Hsu   +9 more
wiley   +1 more source

Leucine enhances the cGAS-STING-NLRP3 pathway in autoimmune thyroiditis. [PDF]

open access: yesJ Transl Autoimmun
Shen X   +8 more
europepmc   +1 more source

Thyroid peroxidase antibodies in children with autoimmune thyroiditis.

open access: green, 1992
Antti Väkevä   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy